• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cellular & Humoral Responses to Flu in Gabonese Children Living in Rural and Semi-urb

sharon sanders

Editor-in-Chief & President
[SIZE=+2]Cellular<SUP> </SUP>and<SUP> </SUP>Humoral<SUP> </SUP>Responses<SUP> </SUP>to<SUP> </SUP>Influenza<SUP> </SUP>in<SUP> </SUP>Gabonese<SUP> </SUP>Children<SUP> </SUP>Living<SUP> </SUP>in<SUP> </SUP>Rural<SUP> </SUP>and<SUP> </SUP>Semi-Urban<SUP> </SUP>Areas<SUP></SUP><SUP> </SUP>[/SIZE]​

[FONT=helvetica, arial][SIZE=-1]E. van Riet,<SUP>1,</SUP><SUP>a</SUP><SUP> </SUP>A. A. Adegnika,<SUP>1,4,5</SUP><SUP> </SUP>K. Retra,<SUP>1,2</SUP><SUP> </SUP>R. Vieira,<SUP>1</SUP><SUP> </SUP>A. G. M. Tielens,<SUP>2</SUP>,<SUP> </SUP>B. Lell,<SUP>4,5</SUP><SUP> </SUP>S. Issifou,<SUP>4</SUP><SUP> </SUP>F. C. Hartgers,<SUP>1</SUP><SUP> </SUP>G. F. Rimmelzwaan,<SUP>3</SUP><SUP> </SUP>P. G. Kremsner,<SUP>4,5</SUP><SUP> </SUP>and<SUP> </SUP>M. Yazdanbakhsh<SUP>1,4</SUP><SUP> </SUP>[/SIZE][/FONT][FONT=helvetica, arial][SIZE=-1]<SUP>1</SUP>Department<SUP> </SUP>of<SUP> </SUP>Parasitology,<SUP> </SUP>Leiden<SUP> </SUP>University<SUP> </SUP>Medical<SUP> </SUP>Center,<SUP> </SUP>Leiden,<SUP> </SUP><SUP>2</SUP>Department<SUP> </SUP>of<SUP> </SUP>Biochemistry<SUP> </SUP>and<SUP> </SUP>Cell<SUP> </SUP>Biology,<SUP> </SUP>Faculty<SUP> </SUP>of<SUP> </SUP>Veterinary<SUP> </SUP>Medicine,<SUP> </SUP>Utrecht<SUP> </SUP>University,<SUP> </SUP>Utrecht,<SUP> </SUP>and<SUP> </SUP><SUP>3</SUP>Department<SUP> </SUP>of<SUP> </SUP>Virology<SUP> </SUP>and<SUP> </SUP>National<SUP> </SUP>Influenza<SUP> </SUP>Center,<SUP> </SUP>Erasmus<SUP> </SUP>Medical<SUP> </SUP>Center,<SUP> </SUP>Rotterdam,<SUP> </SUP>The<SUP> </SUP>Netherlands;<SUP> </SUP><SUP>4</SUP>Medical<SUP> </SUP>Research<SUP> </SUP>Unit,<SUP> </SUP>Albert<SUP> </SUP>Schweitzer<SUP> </SUP>Hospital,<SUP> </SUP>Lambar?n?,<SUP> </SUP>Gabon;<SUP> </SUP><SUP>5</SUP>Department<SUP> </SUP>of<SUP> </SUP>Human<SUP> </SUP>Parasitology,<SUP> </SUP>Institute<SUP> </SUP>for<SUP> </SUP>Tropical<SUP> </SUP>Medicine,<SUP> </SUP>T?bingen<SUP> </SUP>University,<SUP> </SUP>T?bingen,<SUP> </SUP>Germany<SUP> </SUP>[/SIZE][/FONT]

</B>
<CENTER><TABLE cellSpacing=0 cellPadding=0 width="80%" border=0><TBODY><TR><TD>
Background. With the current attention<SUP> </SUP>to the pandemic threat<SUP> </SUP>of avian influenza viruses,<SUP> </SUP>it is recognized that<SUP> </SUP>there is little information<SUP> </SUP>on influenza in Africa.<SUP> </SUP>In addition, the effects<SUP> </SUP>of influenza vaccination in<SUP> </SUP>African countries could be<SUP> </SUP>very different from the<SUP> </SUP>effects in regions with<SUP> </SUP>less exposure to microorganisms<SUP> </SUP>and parasites.
Methods. To monitor the<SUP> </SUP>presence of influenza viruses<SUP> </SUP>and investigate the immunological<SUP> </SUP>responses to influenza vaccination,<SUP> </SUP>schoolchildren in semi-urban and<SUP> </SUP>rural regions of Gabon<SUP> </SUP>were studied. Influenza-specific antibody<SUP> </SUP>responses to the 3<SUP> </SUP>strains represented in the<SUP> </SUP>vaccine were determined in<SUP> </SUP>the serum. Furthermore, cytokine<SUP> </SUP>responses were measured after<SUP> </SUP>in vitro stimulation of<SUP> </SUP>whole blood by influenza<SUP> </SUP>antigens, before and after<SUP> </SUP>vaccination.<SUP> </SUP>
Results. Prevaccination titers of antibody<SUP> </SUP>against H3N2 were high.<SUP> </SUP>At vaccination, the titers<SUP> </SUP>of antibody against the<SUP> </SUP>3 influenza strains increased<SUP> </SUP>significantly. The anti-H1N1 and<SUP> </SUP>anti-B responses after vaccination<SUP> </SUP>were weaker in rural<SUP> </SUP>schoolchildren than in semi-urban<SUP> </SUP>schoolchildren. Influenza-specific cytokine responses<SUP> </SUP>were induced within a<SUP> </SUP>week, showing significantly lower<SUP> </SUP>interferon-
gamma.gif
and significantly higher<SUP> </SUP>interleukin-5 in the children<SUP> </SUP>from rural areas.<SUP> </SUP>
Conclusions. Prevaccination antibody<SUP> </SUP>levels indicated that influenza<SUP> </SUP>viruses circulate in Gabon.<SUP> </SUP>Altogether, influenza vaccination induces<SUP> </SUP>weaker immune responses in<SUP> </SUP>a rural population than<SUP> </SUP>in a semi-urban population<SUP> </SUP>of Gabonese schoolchildren.<SUP> </SUP>

</TD></TR></TBODY></TABLE></CENTER><HR>
[SIZE=-1] Received 15 March 2007; accepted 31 May 2007; electronically published 22 October 2007.[/SIZE]<SUP> </SUP>
[SIZE=-1] Potential conflicts<SUP> </SUP>of interest: none reported.<SUP> </SUP>
Financial<SUP> </SUP>support: Dutch Organization for<SUP> </SUP>Scientific Research (ZonMW TOP<SUP> </SUP>programme grant 912-03-048 to<SUP> </SUP>M.Y. and F.C.H.); European<SUP> </SUP>commission (INCO programme grant<SUP> </SUP>CT2006-031714 to M.Y. and<SUP> </SUP>E.v.R.); Netherlands Foundation for<SUP> </SUP>the Advancement of Tropical<SUP> </SUP>Research (contract W95-367 to<SUP> </SUP>K.R.).<SUP> </SUP>[/SIZE]
[SIZE=-1] <SUP>a</SUP> Present affiliation: Division of<SUP> </SUP>Drug Delivery Technology, Leiden<SUP> </SUP>Amsterdam Center for Drug<SUP> </SUP>Research, Leiden, The Netherlands.<SUP> </SUP>[/SIZE]
[SIZE=-1] Reprints<SUP> </SUP>or<SUP> </SUP>correspondence:<SUP> </SUP>E.<SUP> </SUP>van<SUP> </SUP>Riet,<SUP> </SUP>Dept.<SUP> </SUP>of<SUP> </SUP>Parasitology,<SUP> </SUP>Leiden<SUP> </SUP>University<SUP> </SUP>Medical<SUP> </SUP>Center,<SUP> </SUP>P.O.<SUP> </SUP>Box<SUP> </SUP>9600,<SUP> </SUP>2300<SUP> </SUP>RC<SUP> </SUP>Leiden,<SUP> </SUP>The<SUP> </SUP>Netherlands<SUP> </SUP>(evanriet@lacdr.leidenuniv.nl).[/SIZE]


<HR> Little<SUP> </SUP>information is available on<SUP> </SUP>influenza in Africa. Influenza-surveillance<SUP> </SUP>capacity is weak on<SUP> </SUP>this continent, and only<SUP> </SUP>2 countries, South Africa<SUP> </SUP>and Senegal, engage in<SUP> </SUP>active monitoring of the<SUP> </SUP>infection and disease [1].<SUP> </SUP>Along with the global<SUP> </SUP>anxiety over the spread<SUP> </SUP>of H5N1 avian influenza,<SUP> </SUP>concerns have been raised<SUP> </SUP>about the lack of<SUP> </SUP>accurate data from the<SUP> </SUP>African continent [1http://www.journals.uchicago.edu/JID/journal/issues/v196n11/38547/38547.text.html#rf2http://www.journals.uchicago.edu/JID/journal/issues/v196n11/38547/38547.text.html#rf3?4]. In<SUP> </SUP>the few sporadic studies<SUP> </SUP>conducted in Africa, involving<SUP> </SUP>virological assessments, it appears<SUP> </SUP>that the problem of<SUP> </SUP>influenza virus is probably<SUP> </SUP>greatly underestimated. In the<SUP> </SUP>areas studied, the virus<SUP> </SUP>was found to be<SUP> </SUP>present and to either<SUP> </SUP>circulate throughout the year<SUP> </SUP>or peak seasonally [2].<SUP> </SUP>The reporting of influenza,<SUP> </SUP>based on clinical manifestations,<SUP> </SUP>is difficult in Africa,<SUP> </SUP>because symptoms are shared<SUP> </SUP>with many other infections<SUP> </SUP>that are prevalent in<SUP> </SUP>the region, making collection<SUP> </SUP>of data on morbidity<SUP> </SUP>and mortality particularly difficult.<SUP> </SUP>Such data are needed<SUP> </SUP>to trace the virus<SUP> </SUP>globally and also to<SUP> </SUP>identify people at the<SUP> </SUP>highest risk who would<SUP> </SUP>benefit from preventive vaccination.<SUP> </SUP>
Considering<SUP> </SUP>vaccination, we find that<SUP> </SUP>even less is known<SUP> </SUP>about the effectiveness of<SUP> </SUP>influenza vaccines in Africa.<SUP> </SUP>With the current attention<SUP> </SUP>to the pandemic threat<SUP> </SUP>of avian influenza viruses,<SUP> </SUP>its global spread, and<SUP> </SUP>the preparation of preventive<SUP> </SUP>and curative vaccines, it<SUP> </SUP>is important to start<SUP> </SUP>asking what the immunological<SUP> </SUP>consequences of influenza vaccination<SUP> </SUP>are in African populations.<SUP> </SUP>These vaccines are mostly<SUP> </SUP>developed and tested in<SUP> </SUP>Europe, in North America,<SUP> </SUP>and in some parts<SUP> </SUP>of Asia. It is<SUP> </SUP>known that vaccines that<SUP> </SUP>have performed well in<SUP> </SUP>populations living in high-income<SUP> </SUP>countries might perform less<SUP> </SUP>well in populations living<SUP> </SUP>in low-income countries [5,<SUP> </SUP>6].<SUP> </SUP>
The conditions found in<SUP> </SUP>the urban centers of<SUP> </SUP>Africa (those with high-<SUP> </SUP>to middle-income populations) might<SUP> </SUP>approximate those found in<SUP> </SUP>the urban centers of<SUP> </SUP>western and industrialized countries.<SUP> </SUP>However, the conditions (i.e.,<SUP> </SUP>lifestyle and exposure to<SUP> </SUP>infection) found in the<SUP> </SUP>rural areas of Africa<SUP> </SUP>vary widely. Many infectious<SUP> </SUP>diseases prevalent in Africa,<SUP> </SUP>particularly those present in<SUP> </SUP>rural areas and chronic<SUP> </SUP>in nature, are known<SUP> </SUP>to be associated with<SUP> </SUP>profound alternations of the<SUP> </SUP>innate [7http://www.journals.uchicago.edu/JID/journal/issues/v196n11/38547/38547.text.html#rf8?9] and the<SUP> </SUP>adaptive [10http://www.journals.uchicago.edu/JID/journal/issues/v196n11/38547/38547.text.html#rf11?12] immune system,<SUP> </SUP>which may affect responses<SUP> </SUP>to third-party antigens. For<SUP> </SUP>example, chronic helminth infections,<SUP> </SUP>which are highly prevalent<SUP> </SUP>in many rural areas<SUP> </SUP>of Africa, are known<SUP> </SUP>to be associated with<SUP> </SUP>the skewing of immune<SUP> </SUP>responses toward Th2 [13].<SUP> </SUP>Moreover, infections with some<SUP> </SUP>parasitic helminths and protozoa,<SUP> </SUP>along with mycobacterial, malarial,<SUP> </SUP>and viral hepatitis infections,<SUP> </SUP>have been shown to<SUP> </SUP>induce regulatory immune responses<SUP> </SUP>that are characterized by<SUP> </SUP>production of high levels<SUP> </SUP>of suppressory cytokines such<SUP> </SUP>as transforming growth factor?
beta.gif
<SUP> </SUP>and interleukin (IL)?10 [14http://www.journals.uchicago.edu/JID/journal/issues/v196n11/38547/38547.text.html#rf15http://www.journals.uchicago.edu/JID/journal/issues/v196n11/38547/38547.text.html#rf16http://www.journals.uchicago.edu/JID/journal/issues/v196n11/38547/38547.text.html#rf17?18].<SUP> </SUP>These suppressory molecules might<SUP> </SUP>affect responses to vaccines,<SUP> </SUP>as already has been<SUP> </SUP>documented for oral vaccines<SUP> </SUP>as well as for<SUP> </SUP>tetanus and bacille Calmette-Gu?rin<SUP> </SUP>(BCG) vaccination [19http://www.journals.uchicago.edu/JID/journal/issues/v196n11/38547/38547.text.html#rf20?21].<SUP> </SUP>
To our<SUP> </SUP>knowledge, influenza surveillance has<SUP> </SUP>never been conducted in<SUP> </SUP>Gabon, and, because the<SUP> </SUP>symptoms of influenza infection<SUP> </SUP>closely resemble those of<SUP> </SUP>prevalent infections such as<SUP> </SUP>malaria, influenza is clinically<SUP> </SUP>not distinguishable. Therefore, antibody<SUP> </SUP>and cellular responses to<SUP> </SUP>influenza A and B<SUP> </SUP>strains were analyzed in<SUP> </SUP>the sera of schoolchildren<SUP> </SUP>residing in rural and<SUP> </SUP>semi-urban areas of Gabon.<SUP> </SUP>Subsequently, the children received<SUP> </SUP>1 dose each of<SUP> </SUP>influenza vaccine, and their<SUP> </SUP>immune responses at various<SUP> </SUP>intervals after vaccination were<SUP> </SUP>monitored.<SUP> </SUP>
[FONT=helvetica, arial][SIZE=+1]MATERIALS AND METHODS<SUP> </SUP>[/SIZE][/FONT]
Study population. The study was conducted<SUP> </SUP>in and around Lambar?n?<SUP> </SUP>in Gabon, Africa. The<SUP> </SUP>children were from 2<SUP> </SUP>schools, one in a<SUP> </SUP>semi-urban area (Lambar?n?) and<SUP> </SUP>the other in a<SUP> </SUP>rural area (PK15). Their<SUP> </SUP>parents were informed of<SUP> </SUP>the study, and written<SUP> </SUP>informed consents were received<SUP> </SUP>prior to inclusion. The<SUP> </SUP>exclusion criteria were (1)<SUP> </SUP>the absence of informed<SUP> </SUP>consent; (2) the absence<SUP> </SUP>of stool, urine, or<SUP> </SUP>blood samples for parasitological<SUP> </SUP>analysis; and (3) the<SUP> </SUP>presence of any clinical<SUP> </SUP>symptoms. A total of<SUP> </SUP>33 children from the<SUP> </SUP>semi-urban school and 22<SUP> </SUP>children from the rural<SUP> </SUP>school agreed to participate<SUP> </SUP>in the study and<SUP> </SUP>met the inclusion criteria.<SUP> </SUP>The details of the<SUP> </SUP>children are shown in<SUP> </SUP>table 1. The 2 cohorts<SUP> </SUP>of children who were<SUP> </SUP>included in the study<SUP> </SUP>were similar with respect<SUP> </SUP>to age and sex<SUP> </SUP>ratio. Nutritional status was<SUP> </SUP>determined by measuring age-<SUP> </SUP>and sex-adjusted weight, and<SUP> </SUP>by comparing this with<SUP> </SUP>age- and sex-specific values<SUP> </SUP>provided by the Center<SUP> </SUP>for Disease Control and<SUP> </SUP>Prevention (CDC) [22]. For<SUP> </SUP>comparisons, we considered well-nourished<SUP> </SUP>children as being those<SUP> </SUP>with an age- and<SUP> </SUP>sex-adjusted weight >90% of<SUP> </SUP>the median corresponding age-<SUP> </SUP>and sex-adjusted weight of<SUP> </SUP>CDC reference data.<SUP> </SUP>
<TABLE cellSpacing=10><TBODY><TR><TD vAlign=top align=middle></TD><TD vAlign=top align=left>[FONT=helvetica, arial][SIZE=-1]Table 1. [/SIZE][/FONT] [FONT=arial,helvetica][SIZE=-1]Study population.[/SIZE][/FONT]</TD></TR></TBODY></TABLE>
Among<SUP> </SUP>the cohorts investigated in<SUP> </SUP>this study, 33% of<SUP> </SUP>the children in the<SUP> </SUP>semi-urban school were infected<SUP> </SUP>with <!--Start Italic-->Schistosoma haematobium<!--End Italic-->, whereas 100%<SUP> </SUP>of the children in<SUP> </SUP>the rural school were<SUP> </SUP>infected. These results were<SUP> </SUP>obtained after 3 independent<SUP> </SUP>urine samples were tested.<SUP> </SUP>The prevalence after testing<SUP> </SUP>1 urine sample was<SUP> </SUP>19% in the semi-urban<SUP> </SUP>school and 78% in<SUP> </SUP>the rural schools. The<SUP> </SUP>prevalence of intestinal helminth<SUP> </SUP>infections in the semi-urban<SUP> </SUP>school and in the<SUP> </SUP>rural school was also<SUP> </SUP>significantly different for both<SUP> </SUP><!--Start Italic-->Ascaris lumbricoides<!--End Italic--> (15% and 55%,<SUP> </SUP>respectively; <!--Start Italic-->P<!--End Italic--> = .002)<SUP> </SUP>and <!--Start Italic-->Trichuris trichiuria<!--End Italic--> (12% and<SUP> </SUP>64%, respectively; <!--Start Italic-->P<!--End Italic--> <<SUP> </SUP>.001). These values were<SUP> </SUP>obtained after 2 stool<SUP> </SUP>samples were examined using<SUP> </SUP>the Kato-Katz method.<SUP> </SUP>
Of the<SUP> </SUP>55 children, 12 were<SUP> </SUP>found to be positive<SUP> </SUP>for malaria during the<SUP> </SUP>study. Of these 12,<SUP> </SUP>2 were infected with<SUP> </SUP><!--Start Italic-->Plasmodium malariae<!--End Italic--> and were treated<SUP> </SUP>with chloroquine (10 mg/kg/day<SUP> </SUP>for 2 days and<SUP> </SUP>5 mg/kg/day on the<SUP> </SUP>third day). The remaining<SUP> </SUP>10 children were found<SUP> </SUP>to be positive for<SUP> </SUP><!--Start Italic-->P. falciparum<!--End Italic--> and were treated<SUP> </SUP>when clinical manifestations were<SUP> </SUP>present. Of these 10,<SUP> </SUP>2 presented symptoms of<SUP> </SUP>malaria infection and were<SUP> </SUP>treated with sulfadoxin (25<SUP> </SUP>mg/kg, single dose) and<SUP> </SUP>pyrimethamin (1.25 mg/kg, single<SUP> </SUP>dose), as well as<SUP> </SUP>with artesunate (4 mg/kg/day<SUP> </SUP>for 3 days). An<SUP> </SUP>additional 4 children whose<SUP> </SUP>positivity was reported during<SUP> </SUP>the study were treated<SUP> </SUP>with sulfadoxin and pyrimethamin<SUP> </SUP>because of physical complaints.<SUP> </SUP>
The<SUP> </SUP>study was approved by<SUP> </SUP>the ethics committee of<SUP> </SUP>the International Foundation of<SUP> </SUP>the Albert Schweitzer Hospital<SUP> </SUP>in Lambar?n?.<SUP> </SUP>
Parasitological diagnostics. Infection with <!--Start Italic-->S. haematobium<!--End Italic--><SUP> </SUP>was determined by passing<SUP> </SUP>10 mL of urine<SUP> </SUP>through a filter with<SUP> </SUP>a 10-
mu.gif
m pore size<SUP> </SUP>and staining the eggs<SUP> </SUP>with a ninhydrin solution.<SUP> </SUP>From children testing negative,<SUP> </SUP>2 additional urine samples<SUP> </SUP>were analyzed, to increase<SUP> </SUP>the accuracy of the<SUP> </SUP>diagnosis. Infection with malaria<SUP> </SUP>parasites was determined by<SUP> </SUP>the staining of thick<SUP> </SUP>blood smears with Giemsa,<SUP> </SUP>as described elsewhere [23].<SUP> </SUP>The presence of the<SUP> </SUP>intestinal helminths, <!--Start Italic-->A. lumbricoides<!--End Italic--> and<SUP> </SUP><!--Start Italic-->T. trichiura,<!--End Italic--> was determined by<SUP> </SUP>analyzing the stool samples,<SUP> </SUP>by the use of<SUP> </SUP>the Kato-Katz method on<SUP> </SUP>1 stool sample at<SUP> </SUP>the very least but<SUP> </SUP>on 2 stool samples<SUP> </SUP>whenever possible [24]. Of<SUP> </SUP>the 55 children, 35<SUP> </SUP>were infected with 1<SUP> </SUP>or more species of<SUP> </SUP>the helminths examined. Subsequent<SUP> </SUP>to the collection of<SUP> </SUP>blood samples at day<SUP> </SUP>28 after vaccination, all<SUP> </SUP>children were treated with<SUP> </SUP>a single dose of<SUP> </SUP>albendazole (400 mg), and<SUP> </SUP>those children whose urine<SUP> </SUP>samples had <!--Start Italic-->S. haematobium<!--End Italic--> eggs<SUP> </SUP>detected in them were<SUP> </SUP>additionally treated with a<SUP> </SUP>single dose of praziquantel<SUP> </SUP>(40 mg/kg).<SUP> </SUP>
Vaccination and sample collection. On day 0,<SUP> </SUP>before vaccination, 3 mL<SUP> </SUP>of heparinated blood was<SUP> </SUP>used for immunological tests.<SUP> </SUP>Children were then vaccinated<SUP> </SUP>against influenza (Begrivac 2004/2005;<SUP> </SUP>Chiron Behring GmbH) and<SUP> </SUP>tetanus (NIPHE). Subsequently, 3<SUP> </SUP>mL of heparinated blood<SUP> </SUP>was drawn on days<SUP> </SUP>2, 4, 7, 14,<SUP> </SUP>and 28 after vaccination,<SUP> </SUP>for use in immunological<SUP> </SUP>assays. At all time<SUP> </SUP>points, the plasma was<SUP> </SUP>frozen and kept at<SUP> </SUP>-20?C, and on all<SUP> </SUP>days except day 28<SUP> </SUP>whole-blood stimulations were performed<SUP> </SUP>to collect supernatants for<SUP> </SUP>cytokine analysis.<SUP> </SUP>
Antibody measurement. For the detection<SUP> </SUP>of serum antibodies against<SUP> </SUP>influenza virus, the haemagglutination<SUP> </SUP>inhibition (HI) assay was<SUP> </SUP>used. The HI assay<SUP> </SUP>was performed in duplicate<SUP> </SUP>according to standard methods<SUP> </SUP>[25, 26], by the<SUP> </SUP>use of turkey erythrocytes<SUP> </SUP>and 4 haemagglutinating units<SUP> </SUP>of the vaccine strains,<SUP> </SUP>which were propagated in<SUP> </SUP>11-day?old embryonated chicken eggs.<SUP> </SUP>Ferret sera raised against<SUP> </SUP>the test antigens were<SUP> </SUP>used as positive controls.<SUP> </SUP>Serum samples were treated<SUP> </SUP>with cholera filtrate to<SUP> </SUP>remove nonspecific anti-haemagglutinins. To<SUP> </SUP>ensure comparability, all serum<SUP> </SUP>samples, collected at different<SUP> </SUP>time points, were tested<SUP> </SUP>at the same time.<SUP> </SUP>For sera with titers<SUP> </SUP>below the detection level,<SUP> </SUP>a value of 5<SUP> </SUP>was assigned. The virus-neutralization<SUP> </SUP>assay was performed according<SUP> </SUP>to standard procedures, as<SUP> </SUP>described previously [27].<SUP> </SUP>
Whole-blood culture and cytokine measurement. Cellular immunological<SUP> </SUP>analysis involved the culturing<SUP> </SUP>of whole blood; 100<SUP> </SUP>
mu.gif
L of blood was<SUP> </SUP>cultured with either 100<SUP> </SUP>
mu.gif
L of RPMI 1640<SUP> </SUP>medium or influenza vaccine<SUP> </SUP>in medium (predetermined optimum,<SUP> </SUP>1
mu.gif
g of HA/mL).<SUP> </SUP>Supernatant was collected after<SUP> </SUP>72 h of incubation<SUP> </SUP>and was kept at<SUP> </SUP>-20?C until analysis.<SUP> </SUP>
Levels of<SUP> </SUP>interferon (IFN)?
gamma.gif
, IL-5, IL-13,<SUP> </SUP>tumor necrosis factor (TNF)?
alpha.gif
,<SUP> </SUP>and IL-10 were determined<SUP> </SUP>simultaneously in the supernatants<SUP> </SUP>by using the Luminex-100<SUP> </SUP>cytometer (Luminex), equipped with<SUP> </SUP>StarStation software (Applied Cytometry<SUP> </SUP>Systems). Buffer-reagent kits and<SUP> </SUP>Luminex cytokine kits (BioSource)<SUP> </SUP>were used, and cytokines<SUP> </SUP>were measured according to<SUP> </SUP>the protocol, with slight<SUP> </SUP>modifications. In brief, assays<SUP> </SUP>were performed in 96-well<SUP> </SUP>round-bottom plates (Nunc) at<SUP> </SUP>room temperature. A mix<SUP> </SUP>of beads was incubated<SUP> </SUP>with a standard or<SUP> </SUP>with samples, or left<SUP> </SUP>blank, in a final<SUP> </SUP>volume of 50
mu.gif
L<SUP> </SUP>for 2 h under<SUP> </SUP>continuous shaking. Plates were<SUP> </SUP>washed twice and incubated<SUP> </SUP>with a cocktail of<SUP> </SUP>biotinylated antibodies (25
mu.gif
L/well)<SUP> </SUP>for 1 h. After<SUP> </SUP>removal of excess biotinylated<SUP> </SUP>antibodies by 2 washes,<SUP> </SUP>streptavidin-RPE was added and<SUP> </SUP>was incubated for 30<SUP> </SUP>min. Subsequently, the plates<SUP> </SUP>were washed a final<SUP> </SUP>time and were analyzed<SUP> </SUP>using the Luminex-100 cytometer.<SUP> </SUP>The lower detection limit<SUP> </SUP>of the assays was<SUP> </SUP>3 pg/mL for IL-5,<SUP> </SUP>5 pg/mL for IL-10<SUP> </SUP>and IFN-
gamma.gif
, and 10<SUP> </SUP>pg/mL for IL-13 and<SUP> </SUP>TNF-
alpha.gif
. Samples with concentrations<SUP> </SUP>below the detection limit<SUP> </SUP>were assigned the relevant<SUP> </SUP>threshold value. To determine<SUP> </SUP>influenza-specific cytokine production, background<SUP> </SUP>cytokine production (cultured with<SUP> </SUP>medium only) was subtracted<SUP> </SUP>from the values obtained<SUP> </SUP>after stimulation of the<SUP> </SUP>blood cells with the<SUP> </SUP>influenza vaccine.<SUP> </SUP>
Statistical analysis. Intergroup differences in<SUP> </SUP>age, sex, nutritional status,<SUP> </SUP>and prevalence of parasitic<SUP> </SUP>infections were tested using<SUP> </SUP>Pearson's
chi.gif
<SUP>2</SUP> test. Cytokine<SUP> </SUP>and antibody levels were<SUP> </SUP>not normally distributed, and<SUP> </SUP>the Mann-Whitney <!--Start Italic-->U<!--End Italic--> test<SUP> </SUP>was used to analyze<SUP> </SUP>these data. Logarithmic transformation<SUP> </SUP>of cytokine and antibody<SUP> </SUP>levels resulted in a<SUP> </SUP>normal distribution, and these<SUP> </SUP>values were used for<SUP> </SUP>linear regression analysis. Results<SUP> </SUP>from statistical analyses, by<SUP> </SUP>SPSS or Graph Pad<SUP> </SUP>Prism, were considered significant<SUP> </SUP>when the <!--Start Italic-->P<!--End Italic--> value<SUP> </SUP>was <.05.<SUP> </SUP>
[FONT=helvetica, arial][SIZE=+1]RESULTS<SUP> </SUP>[/SIZE][/FONT]
Seroprevalence of antibodies to influenza viruses prior to vaccination. Results obtained with<SUP> </SUP>the HI assay showed<SUP> </SUP>that influenza virus?specific antibodies<SUP> </SUP>were already present in<SUP> </SUP>the majority of sera<SUP> </SUP>before vaccination (figure 1), indicating<SUP> </SUP>that influenza A viruses<SUP> </SUP>of the H1N1 and<SUP> </SUP>H3N2 subtypes and influenza<SUP> </SUP>B virus have been<SUP> </SUP>circulating in Gabon prior<SUP> </SUP>to the present study.<SUP> </SUP>Interestingly, before vaccination, the<SUP> </SUP>antibodies specific to the<SUP> </SUP>H3N2 strain A/Wyoming/3/2003 had<SUP> </SUP>a higher seroprevalance than<SUP> </SUP>did those specific to<SUP> </SUP>the influenza H1N1 and<SUP> </SUP>B strains. The presence<SUP> </SUP>of high titers of<SUP> </SUP>preexisting antibody was confirmed<SUP> </SUP>using an alternative method<SUP> </SUP>for influenza serology. A<SUP> </SUP>virus-neutralization assay was performed<SUP> </SUP>with the sera obtained<SUP> </SUP>from a subset of<SUP> </SUP>19 children from both<SUP> </SUP>study groups, each showing<SUP> </SUP>similar titers: 1593 (range,<SUP> </SUP>160?20,480) and 1481 (range,<SUP> </SUP>80?10,240) for the HI<SUP> </SUP>and neutralization assays, respectively.<SUP> </SUP>Thus, the prevaccination A/Wyoming/3/2003<SUP> </SUP>X147 (H3N2)?specific antibody levels<SUP> </SUP>indicate that an outbreak<SUP> </SUP>of infection caused by<SUP> </SUP>a strain related to<SUP> </SUP>A/Wyoming/3/2003 must have occurred<SUP> </SUP>recently.<SUP> </SUP>
<TABLE cellSpacing=10><TBODY><TR><TD vAlign=top align=middle>
[SIZE=-1](38 kB)[/SIZE]</TD><TD vAlign=top align=left>[FONT=arial,helvetica][SIZE=-1]Figure 1. [/SIZE][/FONT][FONT=arial,helvetica][SIZE=-1]Haemagglutination inhibition (HI) titers<SUP> </SUP>of antibody against the<SUP> </SUP>3 influenza strains present<SUP> </SUP>in the vaccine before<SUP> </SUP>and 14 and 28<SUP> </SUP>days after vaccination. Graphs<SUP> </SUP><!--Start Italic-->A<!--End Italic-->?<!--Start Italic-->C<!--End Italic--> show the individual<SUP> </SUP>data; graphs <!--Start Italic-->D<!--End Italic-->?<!--Start Italic-->F<!--End Italic--> show<SUP> </SUP>the kinetics of the<SUP> </SUP>responses, with the geometric<SUP> </SUP>mean titers per group.<SUP> </SUP>(<!--Start Italic-->A<!--End Italic--> and <!--Start Italic-->D<!--End Italic-->) A/New<SUP> </SUP>Caledonia/20/99, IVR-116 (H1N1); (<!--Start Italic-->B<!--End Italic--><SUP> </SUP>and <!--Start Italic-->E<!--End Italic-->) B/Jiangsu/10/2003; (<!--Start Italic-->C<!--End Italic--><SUP> </SUP>and <!--Start Italic-->F<!--End Italic-->) A/Wyoming/3/2003 X147(H3N2).<SUP> </SUP>The filled triangles and<SUP> </SUP>solid lines represent semi-urban<SUP> </SUP>(sU) subjects; the open<SUP> </SUP>circles and dashed lines<SUP> </SUP>represent rural (R) subjects.<SUP> </SUP>*<!--Start Italic-->P<!--End Italic--> < .05 (Mann-Whitney<SUP> </SUP><!--Start Italic-->U<!--End Italic--> test).[/SIZE][/FONT]
</TD></TR></TBODY></TABLE>
Efficacy of vaccination: antibody production. The antibody responses<SUP> </SUP>to the 3 different<SUP> </SUP>influenza virus strains present<SUP> </SUP>in the vaccine were<SUP> </SUP>determined not only before<SUP> </SUP>but also 14 and<SUP> </SUP>28 days after vaccination<SUP> </SUP>(figure 1). At vaccination, HI<SUP> </SUP>titers of antibody against<SUP> </SUP>the influenza A (H1N1)<SUP> </SUP>strain increased in both<SUP> </SUP>the rural and semi-urban<SUP> </SUP>schoolchildren, but, on day<SUP> </SUP>28, they reached significantly<SUP> </SUP>higher levels in the<SUP> </SUP>semi-urban schoolchildren (figure 1<!--Start Italic-->A<!--End Italic--><SUP> </SUP>and 1<!--Start Italic-->D<!--End Italic-->). Two groups<SUP> </SUP>of children could be<SUP> </SUP>identified, one whose anti-H1N1<SUP> </SUP>titers remained at a<SUP> </SUP>level only slightly higher<SUP> </SUP>than the prevaccination values<SUP> </SUP>(low responders) and another<SUP> </SUP>that showed a prominent<SUP> </SUP>increase in antibody responses<SUP> </SUP>(high responders) (figure 1<!--Start Italic-->A<!--End Italic-->). The<SUP> </SUP>latter group was significantly<SUP> </SUP>larger in the semi-urban<SUP> </SUP>population (figure 2<!--Start Italic-->A<!--End Italic-->), resulting in<SUP> </SUP>the overall higher titers<SUP> </SUP>in the semi-urban children.<SUP> </SUP>Within the semi-urban schoolchildren,<SUP> </SUP>those with helminth infections<SUP> </SUP>(<!--Start Italic-->S. mansoni<!--End Italic-->, <!--Start Italic-->A. lumbricoides<!--End Italic-->, and/or <!--Start Italic-->T. trichiuris<!--End Italic-->)<SUP> </SUP>responded differently to the<SUP> </SUP>H1N1 antibody than did<SUP> </SUP>those without it. Thus,<SUP> </SUP>when only the group<SUP> </SUP>without helminth infections was<SUP> </SUP>compared to the rural<SUP> </SUP>cohort, the difference in<SUP> </SUP>H1N1-specific antibody titers became<SUP> </SUP>highly significant (<!--Start Italic-->P<!--End Italic--> <<SUP> </SUP>.01), at both day<SUP> </SUP>14 and day 28<SUP> </SUP>after vaccination. Indeed, in<SUP> </SUP>terms of percentage of<SUP> </SUP>high responders as well,<SUP> </SUP>it was clear that<SUP> </SUP>helminth-infected children in the<SUP> </SUP>semi-urban area responded more<SUP> </SUP>like rural children (figure 2<!--Start Italic-->A<!--End Italic-->).<SUP> </SUP>In addition, infections with<SUP> </SUP>plasmodia affected anti-H1N1 titers<SUP> </SUP>in rural children but<SUP> </SUP>not in semi-urban children.<SUP> </SUP>As shown in figure 2<!--Start Italic-->B<!--End Italic-->,<SUP> </SUP>only a few rural<SUP> </SUP>children with plasmodia were<SUP> </SUP>high responders when anti-H1N1<SUP> </SUP>antibody titers were considered.<SUP> </SUP>
<TABLE cellSpacing=10><TBODY><TR><TD vAlign=top align=middle>
[SIZE=-1](57 kB)[/SIZE]</TD><TD vAlign=top align=left>[FONT=arial,helvetica][SIZE=-1]Figure 2. [/SIZE][/FONT][FONT=arial,helvetica][SIZE=-1]Influence<SUP> </SUP>of helminth (<!--Start Italic-->A<!--End Italic-->) and<SUP> </SUP>malaria (<!--Start Italic-->B<!--End Italic-->) infection on<SUP> </SUP>antibody responses to influenza<SUP> </SUP>A (H1N1). As shown<SUP> </SUP>in figure 1, antibody responses<SUP> </SUP>to the H1N1 strain<SUP> </SUP>were either low or<SUP> </SUP>high. <!--Start Italic-->A<!--End Italic-->, Percentage of<SUP> </SUP>high responders shown for<SUP> </SUP>the total group of<SUP> </SUP>semi-urban (sU) children (both<SUP> </SUP>infected and uninfected; <!--Start Italic-->gray bars<!--End Italic-->),<SUP> </SUP>for the semi-urban children<SUP> </SUP>without any helminth infection<SUP> </SUP>(sU-; <!--Start Italic-->white bars<!--End Italic-->), for the<SUP> </SUP>semi-urban children with a<SUP> </SUP>helminth (schistosome, ascaris, and/or<SUP> </SUP>trichuris) infection (sU+; <!--Start Italic-->black bars<!--End Italic-->),<SUP> </SUP>and for the rural<SUP> </SUP>(R; <!--Start Italic-->gray bars<!--End Italic-->) children (all<SUP> </SUP>infected). <!--Start Italic-->B<!--End Italic-->, Percentage of<SUP> </SUP>high responders for the<SUP> </SUP>total group of semi-urban<SUP> </SUP>(sU) and rural (R)<SUP> </SUP>children (both infected and<SUP> </SUP>uninfected; <!--Start Italic-->gray bars<!--End Italic-->), for the<SUP> </SUP>semi-urban and rural children<SUP> </SUP>without malaria infection (sU-<SUP> </SUP>and R-; <!--Start Italic-->white bars<!--End Italic-->), and<SUP> </SUP>for the semi-urban and<SUP> </SUP>rural children with malaria<SUP> </SUP>infection (sU+ and R+;<SUP> </SUP><!--Start Italic-->black bars<!--End Italic-->). *<!--Start Italic-->P<!--End Italic--> < .05<SUP> </SUP>(
chi.gif
<SUP>2</SUP> test); **<!--Start Italic-->P<!--End Italic-->
les.gif
<SUP> </SUP>.005 (
chi.gif
<SUP>2</SUP> test).[/SIZE][/FONT]
</TD></TR></TBODY></TABLE>
The antibody<SUP> </SUP>titers specific to the<SUP> </SUP>influenza B strain increased<SUP> </SUP>at vaccination, reaching a<SUP> </SUP>peak at 14 days<SUP> </SUP>after vaccination and slightly<SUP> </SUP>decreasing thereafter (figure 1<!--Start Italic-->B<!--End Italic--><SUP> </SUP>and 1<!--Start Italic-->E<!--End Italic-->). Also, for<SUP> </SUP>this strain, responses were<SUP> </SUP>significantly higher in the<SUP> </SUP>semi-urban children at day<SUP> </SUP>28.<SUP> </SUP>
Compared with the prevaccination<SUP> </SUP>antibody levels specific to<SUP> </SUP>the H1N1 or B<SUP> </SUP>strain of the vaccine,<SUP> </SUP>the prevaccination levels of<SUP> </SUP>antibodies specific to the<SUP> </SUP>influenza A (H3N2) strain<SUP> </SUP>were very high, and<SUP> </SUP>they increased slightly at<SUP> </SUP>vaccination. At day 14,<SUP> </SUP>antibody levels were significantly<SUP> </SUP>higher in the rural<SUP> </SUP>schoolchildren than in the<SUP> </SUP>semi-urban children, but this<SUP> </SUP>difference was no longer<SUP> </SUP>significant at day 28<SUP> </SUP>(figure 1<!--Start Italic-->C<!--End Italic--> and 1<!--Start Italic-->F<!--End Italic-->).<SUP> </SUP>For antibodies specific to<SUP> </SUP>influenza B or H3N2<SUP> </SUP>strains, neither helminth nor<SUP> </SUP>malaria infection influenced the<SUP> </SUP>responses significantly.<SUP> </SUP>
Efficacy of vaccination: cytokine responses. The cytokine response<SUP> </SUP>to influenza was determined<SUP> </SUP>at different time points,<SUP> </SUP>to follow the kinetics<SUP> </SUP>of cellular immune response<SUP> </SUP>development following vaccination (figure 3).<SUP> </SUP>After day 2 following<SUP> </SUP>vaccination, cytokine responses started<SUP> </SUP>to rise. The IL-10<SUP> </SUP>response was early, and<SUP> </SUP>a tight peak was<SUP> </SUP>seen in both rural<SUP> </SUP>and semi-urban schoolchildren at<SUP> </SUP>day 4 (figure 3<!--Start Italic-->A<!--End Italic-->). The<SUP> </SUP>magnitude of the influenza-specific<SUP> </SUP>IL-10 response was significantly<SUP> </SUP>higher in the semi-urban<SUP> </SUP>schoolchildren. The TNF-
alpha.gif
, IFN-
gamma.gif
,<SUP> </SUP>and IL-5 responses peaked<SUP> </SUP>at day 7 (figure<SUP> </SUP>3<!--Start Italic-->B<!--End Italic-->?3<!--Start Italic-->D<!--End Italic-->). The TNF-
alpha.gif
levels<SUP> </SUP>were also significantly higher<SUP> </SUP>in the semi-urban schoolchildren;<SUP> </SUP>the peak at day<SUP> </SUP>7 was almost absent<SUP> </SUP>for the rural schoolchildren<SUP> </SUP>(figure 3<!--Start Italic-->B<!--End Italic-->). Starting at day<SUP> </SUP>7 after vaccination, IFN-
gamma.gif
<SUP> </SUP>responses were significantly higher<SUP> </SUP>in semi-urban children (figure 3<!--Start Italic-->C<!--End Italic-->).<SUP> </SUP>In contrast, the rural<SUP> </SUP>schoolchildren showed a more<SUP> </SUP>Th2-skewed response, because they<SUP> </SUP>produced less IFN-
gamma.gif
and<SUP> </SUP>higher levels of IL-5<SUP> </SUP>than did the the<SUP> </SUP>semi-urban schoolchildren (figure 3<!--Start Italic-->D<!--End Italic-->). Interestingly,<SUP> </SUP>IL-5 responses to influenza<SUP> </SUP>were higher in the<SUP> </SUP>helminth-infected semi-urban schoolchildren than<SUP> </SUP>in the noninfected semi-urban<SUP> </SUP>children (insert in figure 3<!--Start Italic-->D<!--End Italic-->),<SUP> </SUP>indicating that the Th2<SUP> </SUP>skewing that is more<SUP> </SUP>prominent in the rural<SUP> </SUP>schoolchildren may, at least<SUP> </SUP>partly, be the result<SUP> </SUP>of the immune-modulating effect<SUP> </SUP>of helminths. Malaria infection<SUP> </SUP>did not affect cytokine<SUP> </SUP>responses to influenza antigens.<SUP> </SUP>
<TABLE cellSpacing=10><TBODY><TR><TD vAlign=top align=middle>
[SIZE=-1](44 kB)[/SIZE]</TD><TD vAlign=top align=left>[FONT=arial,helvetica][SIZE=-1]Figure 3. [/SIZE][/FONT][FONT=arial,helvetica][SIZE=-1]Kinetics<SUP> </SUP>of influenza-specific cytokine production<SUP> </SUP>determined by ex vivo<SUP> </SUP>stimulation of whole blood<SUP> </SUP>before and after influenza<SUP> </SUP>vaccination. The mean values<SUP> </SUP>and the 95% confidence<SUP> </SUP>interval of interleukin (IL)?10<SUP> </SUP><!--Start Italic-->(A)<!--End Italic-->, tumor necrosis factor<SUP> </SUP>(TNF)?
alpha.gif
<!--Start Italic-->(B)<!--End Italic-->, interferon (IFN)?
gamma.gif
<SUP> </SUP><!--Start Italic-->(C)<!--End Italic-->, and IL-5 <!--Start Italic-->(D)<!--End Italic--><SUP> </SUP>are shown. The filled<SUP> </SUP>triangles and solid lines<SUP> </SUP>represent the semi-urban (sU)<SUP> </SUP>cohort; the open circles<SUP> </SUP>and dashed lines represent<SUP> </SUP>the rural (R) cohort.<SUP> </SUP>*<!--Start Italic-->P<!--End Italic--> < .05 (Mann-Whitney<SUP> </SUP><!--Start Italic-->U<!--End Italic--> test); **<!--Start Italic-->P<!--End Italic-->
les.gif
<SUP> </SUP>.005 (Mann-Whitney <!--Start Italic-->U<!--End Italic--> test).<SUP> </SUP>The inset in graph<SUP> </SUP><!--Start Italic-->D<!--End Italic--> shows the IL-5<SUP> </SUP>responses of the semi-urban<SUP> </SUP>children with helminth infection<SUP> </SUP>(sU+) and of the<SUP> </SUP>semi-urban children without helminth<SUP> </SUP>(<!--Start Italic-->S. mansoni<!--End Italic-->, <!--Start Italic-->A lumbricoides<!--End Italic-->, and/or <!--Start Italic-->T. trichiuris<!--End Italic-->)<SUP> </SUP>infection (sU-).[/SIZE][/FONT]
</TD></TR></TBODY></TABLE>
[FONT=helvetica, arial][SIZE=+1]DISCUSSION<SUP> </SUP>[/SIZE][/FONT]
The present study<SUP> </SUP>indicates that influenza A<SUP> </SUP>and B viruses circulate<SUP> </SUP>in Gabon and that<SUP> </SUP>the presence of high<SUP> </SUP>levels of A/Wyoming/3/2003 X147<SUP> </SUP>(H3N2)?specific antibodies before vaccination,<SUP> </SUP>as determined by an<SUP> </SUP>HI assay and a<SUP> </SUP>neutralization assay, provides us<SUP> </SUP>with evidence for a<SUP> </SUP>recent outbreak of a<SUP> </SUP>H3N2 virus. Sporadic monitoring<SUP> </SUP>of influenza in other<SUP> </SUP>African countries has revealed<SUP> </SUP>outbreaks of H3N2 virus<SUP> </SUP>in South Africa in<SUP> </SUP>2003 [28], in Madagascar<SUP> </SUP>in 2002 [2], and<SUP> </SUP>in the Democratic Republic<SUP> </SUP>of Congo in 2002<SUP> </SUP>[2]. In addition, influenza<SUP> </SUP>B viruses have been<SUP> </SUP>reported to be circulating<SUP> </SUP>in South Africa, Madagascar,<SUP> </SUP>and Kenya [29, 30].<SUP> </SUP>
In<SUP> </SUP>some of these studies,<SUP> </SUP>a mortality of at<SUP> </SUP>least 3% of cases<SUP> </SUP>was reported, because of<SUP> </SUP>influenza A/Panama/2007/97-like (H3N2) infection,<SUP> </SUP>indicating that influenza can<SUP> </SUP>have a high impact<SUP> </SUP>in African countries as<SUP> </SUP>well [2]. No data<SUP> </SUP>are available on influenza<SUP> </SUP>mortality or morbidity in<SUP> </SUP>Gabon, and, given our<SUP> </SUP>findings, it would not<SUP> </SUP>be surprising if considerable<SUP> </SUP>mortality in the study<SUP> </SUP>area may be attributed<SUP> </SUP>to influenza epidemics. This<SUP> </SUP>is particularly important for<SUP> </SUP>the area we studied?in<SUP> </SUP>fact, for most of<SUP> </SUP>Africa, where malaria is<SUP> </SUP>endemic and where high<SUP> </SUP>fever is often treated<SUP> </SUP>with antimalarials. Thus, influenza<SUP> </SUP>infections in these areas<SUP> </SUP>can lead to considerable<SUP> </SUP>malaria overmedication, on the<SUP> </SUP>one hand, and to<SUP> </SUP>an overestimation of malaria<SUP> </SUP>deaths, on the other.<SUP> </SUP>
In<SUP> </SUP>vaccine-induced antibody responses, considerable<SUP> </SUP>differences between rural and<SUP> </SUP>semi-urban schoolchildren were observed.<SUP> </SUP>The responses to H1N1<SUP> </SUP>and influenza B strains<SUP> </SUP>were higher in the<SUP> </SUP>schoolchildren from the semi-urban<SUP> </SUP>area. Because the prevaccination<SUP> </SUP>titers did not differ<SUP> </SUP>between semi-urban and rural<SUP> </SUP>schoolchildren, it is unlikely<SUP> </SUP>that differences in exposure<SUP> </SUP>to influenza could explain<SUP> </SUP>these results. Why the<SUP> </SUP>schoolchildren in rural areas<SUP> </SUP>would respond differently from<SUP> </SUP>those in semi-urban areas<SUP> </SUP>has yet to be<SUP> </SUP>fully investigated. However, some<SUP> </SUP>vaccines, such as those<SUP> </SUP>for BCG or tetanus,<SUP> </SUP>which were shown to<SUP> </SUP>be effective in nontropical<SUP> </SUP>countries, were found to<SUP> </SUP>induce a weak response<SUP> </SUP>in tropical countries, and<SUP> </SUP>this has been associated<SUP> </SUP>with the presence of<SUP> </SUP>helminth infections [5, 31].<SUP> </SUP>Moreover, although, to our<SUP> </SUP>knowledge, the effect of<SUP> </SUP>helminth infections on the<SUP> </SUP>efficacy of influenza vaccination<SUP> </SUP>has not been investigated<SUP> </SUP>previously, studies on the<SUP> </SUP>efficacy of the cholera<SUP> </SUP>vaccine [19], the BCG<SUP> </SUP>vaccine [32], and tetanus<SUP> </SUP>toxoid vaccine [20, 33]<SUP> </SUP>suggested to us that<SUP> </SUP>immune skewing in response<SUP> </SUP>to vaccines is affected<SUP> </SUP>by preexisting helminth infections.<SUP> </SUP>These studies were performed<SUP> </SUP>in different areas and<SUP> </SUP>considered intestinal helminth [19,<SUP> </SUP>32], filaria, or schistosome<SUP> </SUP>infections [33, 34]. One<SUP> </SUP>of the major differences<SUP> </SUP>between the Gabonese rural<SUP> </SUP>cohort and the Gabonese<SUP> </SUP>semi-urban cohort investigated in<SUP> </SUP>the present study is<SUP> </SUP>the extent of exposure<SUP> </SUP>to parasitic infections, as<SUP> </SUP>shown in table 1. Helminth<SUP> </SUP>infections were shown to<SUP> </SUP>affect H1N1-specific antibody titers<SUP> </SUP>in semi-urban schoolchildren, as<SUP> </SUP>shown in figure 2<!--Start Italic-->A<!--End Italic-->. In<SUP> </SUP>addition, it was found<SUP> </SUP>that malaria-infected schoolchildren in<SUP> </SUP>the rural cohort were<SUP> </SUP>more often low responders<SUP> </SUP>to H1N1 than were<SUP> </SUP>schoolchildren without malaria infection.<SUP> </SUP>This effect was not<SUP> </SUP>found for the semi-urban<SUP> </SUP>cohort, raising the possibility<SUP> </SUP>that malaria infection in<SUP> </SUP>the helminth-infected group (all<SUP> </SUP>schoolchildren in the rural<SUP> </SUP>area were infected with<SUP> </SUP>helminths) has a strong<SUP> </SUP>suppressory effect. Alternatively, malaria<SUP> </SUP>treatment could have affected<SUP> </SUP>the outcome, although several<SUP> </SUP>studies did not find<SUP> </SUP>that malaria treatment has<SUP> </SUP>a negative effect on<SUP> </SUP>outcome of immunization [35http://www.journals.uchicago.edu/JID/journal/issues/v196n11/38547/38547.text.html#rf36?37];<SUP> </SUP>only long-term treatment with<SUP> </SUP>chloroquine has been associated<SUP> </SUP>with impairment of vaccination<SUP> </SUP>efficacy [38]. However, malaria<SUP> </SUP>infection or treatment did<SUP> </SUP>not seem to affect<SUP> </SUP>the titers of antibody<SUP> </SUP>against the influenza A<SUP> </SUP>(H3N2) or the influenza<SUP> </SUP>B strain, nor did<SUP> </SUP>it affect the cytokine<SUP> </SUP>responses in the present<SUP> </SUP>study.<SUP> </SUP>
Another difference noted between<SUP> </SUP>semi-urban and rural schoolchildren<SUP> </SUP>was nutritional status, as<SUP> </SUP>shown in table 1. However,<SUP> </SUP>the differences between antibody<SUP> </SUP>titers could not be<SUP> </SUP>explained by differences in<SUP> </SUP>nutritional status.<SUP> </SUP>
The anti?A/Wyoming/3/2003 X147<SUP> </SUP>(H3N2) antibody levels, which<SUP> </SUP>were very high before<SUP> </SUP>vaccination, increased further after<SUP> </SUP>vaccination. Interestingly, the postvaccination<SUP> </SUP>antibody titers were higher<SUP> </SUP>in the rural schoolchildren,<SUP> </SUP>but at only day<SUP> </SUP>14 after vaccination. Thus,<SUP> </SUP>postvaccination titers of antibody<SUP> </SUP>against a virus strain<SUP> </SUP>that had circulated recently<SUP> </SUP>were no different from,<SUP> </SUP>or even higher than,<SUP> </SUP>those found in urban<SUP> </SUP>schoolchildren. This is different<SUP> </SUP>from what is observed<SUP> </SUP>with postvaccination titers of<SUP> </SUP>antibody against strains that<SUP> </SUP>have not caused a<SUP> </SUP>recent epidemic. The mechanism<SUP> </SUP>behind this is not<SUP> </SUP>clear, but it may<SUP> </SUP>be based on the<SUP> </SUP>differential requirement for activation<SUP> </SUP>of central or effector<SUP> </SUP>memory T cells [39].<SUP> </SUP>
In<SUP> </SUP>terms of cytokine responses,<SUP> </SUP>the semi-urban schoolchildren show<SUP> </SUP>a stronger influenza-specific Th1<SUP> </SUP>response than do the<SUP> </SUP>rural schoolchildren, as determined<SUP> </SUP>by their increased IFN-
gamma.gif
<SUP> </SUP>levels and their reduced<SUP> </SUP>IL-5 levels. It is<SUP> </SUP>possible that the effects<SUP> </SUP>that helminth infections have<SUP> </SUP>on the antibody responses<SUP> </SUP>in rural areas and<SUP> </SUP>on the characteristic Th2-like<SUP> </SUP>immune responses (as well<SUP> </SUP>as on immunological hyporesponsiveness)<SUP> </SUP>will affect the efficacy<SUP> </SUP>of vaccines [5, 31],<SUP> </SUP>which are expected to<SUP> </SUP>induce a Th1 response,<SUP> </SUP>by skewing cytokine responses<SUP> </SUP>toward Th2.<SUP> </SUP>
Interestingly, there was<SUP> </SUP>a positive correlation (Pearson<SUP> </SUP>correlation coefficient, 0.17; <!--Start Italic-->P<!--End Italic--><SUP> </SUP>= .034) between levels<SUP> </SUP>of IFN-
gamma.gif
production and<SUP> </SUP>nutritional status (weight by<SUP> </SUP>age) in the urban<SUP> </SUP>schoolchildren but not in<SUP> </SUP>the rural schoolchildren (data<SUP> </SUP>not shown). This correlation<SUP> </SUP>was not influenced by<SUP> </SUP>helminth infection. The influence<SUP> </SUP>that nutritional status has<SUP> </SUP>on cytokine production has<SUP> </SUP>not been studied extensively,<SUP> </SUP>but, in a mouse<SUP> </SUP>model, the cytokine production<SUP> </SUP>in response to helminth<SUP> </SUP>antigens was determined by<SUP> </SUP>Shi et al., who<SUP> </SUP>found decreased IFN-
gamma.gif
levels<SUP> </SUP>in response to zinc<SUP> </SUP>deficiency [40].<SUP> </SUP>
TNF-
alpha.gif
responses to<SUP> </SUP>influenza vaccination were significantly<SUP> </SUP>lower in rural shoolchildren.<SUP> </SUP>An increase in production<SUP> </SUP>of IL-10 and/or regulatory<SUP> </SUP>T cell responses could<SUP> </SUP>explain the down-regulation of<SUP> </SUP>Th1 as well as<SUP> </SUP>the proinflammatory TNF-
alpha.gif
responses.<SUP> </SUP>However, we observed an<SUP> </SUP>increased rather than decreased<SUP> </SUP>IL-10 response to influenza<SUP> </SUP>vaccination in the semi-urban<SUP> </SUP>schoolchildren. Although it is<SUP> </SUP>known that high levels<SUP> </SUP>of IL-10 are often<SUP> </SUP>associated with helminth infection<SUP> </SUP>[20, 41], little is<SUP> </SUP>known about the IL-10<SUP> </SUP>response at influenza vaccination.<SUP> </SUP>To fully understand the<SUP> </SUP>detailed cellular responses, more<SUP> </SUP>studies on the source<SUP> </SUP>of IL-10 soon after<SUP> </SUP>vaccination are needed.<SUP> </SUP>
In conclusion,<SUP> </SUP>we report here that<SUP> </SUP>vaccination against the influenza<SUP> </SUP>virus strains that have<SUP> </SUP>not caused a recent<SUP> </SUP>outbreak seems to be<SUP> </SUP>more effective in a<SUP> </SUP>semi-urban population than in<SUP> </SUP>a rural population of<SUP> </SUP>Gabonese schoolchildren. With respect<SUP> </SUP>to cytokine production at<SUP> </SUP>in vitro stimulation of<SUP> </SUP>whole blood by the<SUP> </SUP>vaccine, lower IFN-
gamma.gif
responses<SUP> </SUP>are elicited in a<SUP> </SUP>rural population. Moreover, a<SUP> </SUP>better diagnosis of influenza,<SUP> </SUP>as well as disentangling<SUP> </SUP>it from coendemic diseases<SUP> </SUP>such as malaria, can<SUP> </SUP>have important implications for<SUP> </SUP>over/mismedication. Finally, epidemiological data<SUP> </SUP>on influenza, as well<SUP> </SUP>as on immune responses<SUP> </SUP>to vaccination, will be<SUP> </SUP>critical for proper managment<SUP> </SUP>of influenza epidemics in<SUP> </SUP>Africa.<SUP> </SUP>
[FONT=helvetica, arial]Acknowledgments<SUP> </SUP>[/FONT]
We thank the schoolchildren<SUP> </SUP>of Gabon, for volunteering<SUP> </SUP>for this study; Ludovic<SUP> </SUP>Mewono and Ghyslain Mombo<SUP> </SUP>Ngoma, for help with<SUP> </SUP>sampling; Bart Everts, Nestor<SUP> </SUP>Obiang, and Brigitte Mingombet,<SUP> </SUP>for their technical assistance;<SUP> </SUP>and all the workers<SUP> </SUP>at the Albert Schweitzer<SUP> </SUP>Hospital, for their cooperation.<SUP> </SUP>Furthermore, we thank Ruud<SUP> </SUP>van Beek, for performing<SUP> </SUP>the influenza serology, and<SUP> </SUP>Hae-Won Uh, for help<SUP> </SUP>with the statistical analysis.<SUP> </SUP>
<TABLE cellSpacing=0 cellPadding=0>[FONT=helvetica, arial]References<SUP> </SUP>[/FONT]
<TBODY><TR><TD vAlign=top align=right>1. </TD><TD vAlign=top align=left>Schoub BD, McAnerney JM, Besselaar TG. Regional perspectives on influenza surveillance in Africa. Vaccine 2002; 20:S45?6. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>2. </TD><TD vAlign=top align=left>Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362:1733?45. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>3. </TD><TD vAlign=top align=left>Normile D, Enserink M. Avian influenza: with change in the seasons, bird flu returns. Science 2007; 315:448. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>4. </TD><TD vAlign=top align=left>Moszynski P. Africa is ill equipped to fight a bird flu epidemic. BMJ 2006; 332:380. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>5. </TD><TD vAlign=top align=left>Baily GV. Tuberculosis prevention trial, Madras. Indian J Med Res 1980; 72(Suppl):1?74. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>6. </TD><TD vAlign=top align=left>Rook GAW, Dheda K, Zumla A. Immune systems in developed and developing countries: implications for the design of vaccines that will work where BCG does not. Tuberculosis 2006; 86:152?62. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>7. </TD><TD vAlign=top align=left>van der Kleij D, van den Biggelaar AH, Kruize YC, et al. Responses to toll-like receptor ligands in children living in areas where schistosome infections are endemic. J Infect Dis 2004; 189:1044?51. First citation in article | Full Text | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>8. </TD><TD vAlign=top align=left>Fell AH, Smith NC. Immunity to asexual blood stages of plasmodium: is resistance to acute malaria adaptive or innate? Parasitology Today 1998; 14:364?9. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>9. </TD><TD vAlign=top align=left>Babu S, Blauvelt CP, Kumaraswami V, Nutman TB. Chemokine receptors of T cells and of B cells in lymphatic filarial infection: a role for CCR9 in pathogenesis. J Infect Dis 2005; 191:1018?26. First citation in article | Full Text | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>10. </TD><TD vAlign=top align=left>Mahanty S, King CL, Kumaraswami V, et al. IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J Immunol 1993; 151:3704?11. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>11. </TD><TD vAlign=top align=left>King CL, Medhat A, Malhotra I, et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis: IL-10 modulates lymphocyte reactivity. J Immunol 1996; 156:4715?21. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>12. </TD><TD vAlign=top align=left>Cooper PJ, Chico ME, Sandoval C, et al. Human infection with <!--Start Italic-->Ascaris lumbricoides<!--End Italic--> is associated with a polarized cytokine response. J Infect Dis 2000; 182:1207?13. First citation in article | Full Text | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>13. </TD><TD vAlign=top align=left>Jankovic D, Steinfelder S, Kullberg MC, Sher A. Mechanisms underlying helminth- induced Th2 polarization: default, negative or positive pathways? Chem Immunol Allergy 2006; 90:65?81. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>14. </TD><TD vAlign=top align=left>Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003; 3:733?44. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>15. </TD><TD vAlign=top align=left>Redpath S, Ghazal P, Gascoigne NRJ. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol 2001; 9:86?92. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>16. </TD><TD vAlign=top align=left>Keller CC, Yamo O, Ouma C, et al. Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia. Infect Immun 2006; 74:5249?60. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>17. </TD><TD vAlign=top align=left>Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006; 173:803?10. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>18. </TD><TD vAlign=top align=left>Boettler T, Spangenberg HC, Neumann-Haefelin C, et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005; 79:7860?7. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>19. </TD><TD vAlign=top align=left>Cooper PJ, Chico M, Sandoval C, et al. Human infection with <!--Start Italic-->Ascaris lumbricoides<!--End Italic--> is associated with suppression of the interleukin-2 response to recombinant cholera toxin b subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun 2001; 69:1574?80. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>20. </TD><TD vAlign=top align=left>Cooper PJ, Espinel I, Paredes W, Guderian RH, Nutman TB. Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis 1998; 178:1133?8. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>21. </TD><TD vAlign=top align=left>Elias D, Akuffo H, Pawlowski A, Haile M, Schon T, Britton S. <!--Start Italic-->Schistosoma mansoni<!--End Italic--> infection reduces the protective efficacy of BCG vaccination against virulent <!--Start Italic-->Mycobacterium tuberculosis.<!--End Italic--> Vaccine 2005; 23:1326?34. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>22. </TD><TD vAlign=top align=left>Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109:45?60. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>23. </TD><TD vAlign=top align=left>Planche T, Krishna S, Kombila M, et al. Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg 2001; 65:599?602. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>24. </TD><TD vAlign=top align=left>Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in <!--Start Italic-->Schistosomiasis mansoni.<!--End Italic--> Rev Inst Med Trop Sao Paulo 1972; 14:397?400. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>25. </TD><TD vAlign=top align=left>Palmer DF, Dowdle WR, Coleman MT, Schild GC. Haemagglutination inhibition test. In: Advanced laboratory techniques for influenza diagnosis: procedural guide. Atlanta: US Dept. of Health and Welfare, 1974:25?62. First citation in article<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>26. </TD><TD vAlign=top align=left>Masurel N, Ophof P, de Jong P. Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus. J Hyg (Lond) 1981; 87:201?9. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>27. </TD><TD vAlign=top align=left>Rimmelzwaan GF, Baars M, van Beek R, et al. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. J Gen Virol 1997; 78:757?65. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>28. </TD><TD vAlign=top align=left>Besselaar TG, Botha L, McAnerney JM, Schoub BD. Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003. J Med Virol 2004; 73:71?8. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>29. </TD><TD vAlign=top align=left>World Health Organization. Recommended composition of influenza virus vaccines for use in the 2005 influenza season. Wkly Epidemiol Rec 2004; 79:369?73. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>30. </TD><TD vAlign=top align=left>Gachara G, Ngeranwa J, Magana JM, et al. Influenza virus strains in Nairobi, Kenya. J Clin Virol 2006; 35:117?8. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>31. </TD><TD vAlign=top align=left>Prost A, Schlumberger M, Fayet MT. Response to tetanus immunization in onchocerciasis patients. Ann Trop Med Parasitol 1983; 77:83?5. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>32. </TD><TD vAlign=top align=left>Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Gu?rin (BCG) vaccination. Clin Exp Immunol 2001; 123:219?25. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>33. </TD><TD vAlign=top align=left>Nookala S, Srinivasan S, Kaliraj P, Narayanan RB, Nutman TB. Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis. Infect Immun 2004; 72:2598?604. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>34. </TD><TD vAlign=top align=left>Sabin EA, Araujo MI, Carvalho EM, Pearce EJ. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with <!--Start Italic-->Schistosoma mansoni.<!--End Italic--> J Infect Dis 1996; 173:269?72. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>35. </TD><TD vAlign=top align=left>Barry M, Patterson JE, Tirrell S, Cullen MR, Shope RE. The effect of chloroquine prophylaxis on yellow fever vaccine antibody response: comparison of plaque reduction neutralization test and enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1991; 44:79?82. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>36. </TD><TD vAlign=top align=left>Faucher JF, Binder R, Missinou MA, et al. Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. Clin Infect Dis 2002; 35:1147?54. First citation in article | Full Text | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>37. </TD><TD vAlign=top align=left>Fryauff DJ, Cryz SJ, Widjaja H, et al. Humoral immune response to tetanus-diphtheria vaccine given during extended use of chloroquine or primaquine malaria chemoprophylaxis. J Infect Dis 1998; 177:1762?5. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>38. </TD><TD vAlign=top align=left>Fryauff DJ, Church LW, Richards AL, et al. Lymphocyte response to tetanus toxoid among Indonesian men immunized with tetanus-diphtheria during extended chloroquine or primaquine prophylaxis. J Infect Dis 1997; 176:1644?8. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>39. </TD><TD vAlign=top align=left>Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:745?63. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>40. </TD><TD vAlign=top align=left>Shi HN, Scott ME, Stevenson MM, Koski KG. Energy restriction and zinc deficiency impair the functions of murine T cells and antigen-presenting cells during gastrointestinal nematode infection. J Nutr 1998; 128:20?7. First citation in article | PubMed<SUP> </SUP></TD></TR><TR><TD vAlign=top align=right>41. </TD><TD vAlign=top align=left>van den Biggelaar AH, van Ree R, Rodrigues LC, et al. Decreased atopy in children infected with <!--Start Italic-->Schistosoma haematobium:<!--End Italic--> a role for parasite-induced interleukin-10. Lancet 2000; 356:1723?7. First citation in article | PubMed | CrossRef<SUP> </SUP></TD></TR>

</TABLE>


http://www.journals.uchicago.edu/JID/journal/issues/v196n11/38547/38547.html
 
Back
Top